Lucintel anticipates that North America will be the fastest growing region in the esoteric testing market

   October 18, 2019
According to a new market report published by Lucintel, the future of the esoteric testing market looks promising with opportunities in the independent and reference laboratories and hospital laboratories. The esoteric testing market is expected to grow with a CAGR of 12% from 2019 to 2024. The major drivers for this market are rising geriatric population and subsequent growth in the prevalence of chronic diseases, increasing burden of infectious diseases, rising demand for early disease detection using specialized diagnostic tests, growing awareness of personalized medicine, and increasing funding and research grants for the development of innovative esoteric tests.

To download report brochure, please go to and click "report brochure" tab from the menu.

Different types of test are performed to detect the disease, such as infectious diseases testing, endocrinology testing, oncology testing, immunology testing, genetic testing, toxicology testing, and neurology testing. Infectious diseases is the largest segment of the esoteric testing market.

Chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real time – PCR, flow cytometry, and radioimmunoassay, are the major techniques of the esoteric testing market.

North America will remain the largest region over the forecast period due to increasing number of research activities in healthcare, growing investment in healthcare by major market players, and increasing patient population suffering from chronic diseases.

Labcorp, Quest Diagnostics, Opko Health, Miraca, Myriad Genetics, Sonic Healthcare, Primary Health Care, Healthscope, Foundation Medicine, ACM Global Laboratories, Arup Laboratories, Fulgent Genetics, Invitae, Mayo Medical Laboratories, and Spectra Laboratories are among the major players of esoteric testing.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the esoteric testing market by product type, technology, end user, and region. Lucintel has prepared a comprehensive research report titled "Esoteric Testing Market 2019-2024: Trends, Forecast, and Opportunity Analysis" .The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the esoteric testing market by product type, technology, end user, and region as follows:

By Product Type [$M shipment analysis for 2013 – 2024]:

  • Infectious Diseases Testing

  • Endocrinology Testing

  • Oncology testing

  • Immunology Testing

  • Genetic Testing

  • Toxicology Testing

  • Neurology Testing

  • Others

By Technology [$M shipment analysis for 2013 – 2024]:

  • Chemiluminescence Immunoassay (CLIA)

  • Enzyme-linked Immunosorbent Assay (ELISA)

  • Mass Spectrometry

  • Real Time – PCR

  • Flow Cytometry

  • Radioimmunoassay

  • Others

By End User [$M shipment analysis for 2013 – 2024]:

  • Independent and Reference Laboratories

  • Hospital Laboratories

By Region [$M shipment analysis for 2013 – 2024]:

  • North America

    • United States

    • Canada

    • Mexico

  • Europe

    • United Kingdom

    • Germany

    • France

    • Italy

    • Spain

  • Asia-Pacific

    • China

    • India

    • Japan

  • ROW

    • Brazil

This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link or

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [53]
Chemical [264]
Composites & Advanced Materials [171]
Construction & Industrial [76]
Consumer and Retail [140]
Economic Analysis [86]
Energy & Utility [73]
Finance & Services [10]
Healthcare [79]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [166]
Transportation [143]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on